Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 7/20 | 0.53 |
| ▸ | RAB9A | P51151 | 7/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.53 |
| ▸ | HPGDS | O60760 | 3/20 | 0.51 |
| ▸ | BTK | Q06187 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 5/20 | 0.48 |
| ▸ | METAP1 | P53582 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CCR1 | P32246 | 1/20 | 0.48 |
| ▸ | CCR5 | P51681 | 1/20 | 0.48 |
| ▸ | CCR8 | P51685 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.48 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5478697 | 0.90 | KDM4E (0.59) | NPY5RNPC1RAB9ASMN1; SMN2BTK | |
| SCHEMBL16128032 | 0.88 | SMN1; SMN2 (0.58) | NPY5RNPC1RAB9ASMN1; SMN2HPGDS | |
| SCHEMBL28205258 | 0.86 | METAP1 (0.50) | NPY5RNPC1RAB9ASMN1; SMN2HPGDS | |
| SCHEMBL9111577 | 0.86 | NPY5R (0.45) | NPY5RNPC1RAB9ASMN1; SMN2HPGDS | |
| SCHEMBL19611704 | 0.84 | TGFBR1 (0.57) | NPY5RNPC1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL28014813 | 0.82 | SMN1; SMN2 (0.59) | NPY5RNPC1RAB9ASMN1; SMN2BTK | |
| SCHEMBL28043674 | 0.82 | CBFB (0.53) | NPY5RKMT2AMETAP2L3MBTL1ALDH1A1 | |
| SCHEMBL9109396 | 0.82 | NPY5R (0.42) | NPY5RNPC1RAB9ASMN1; SMN2HPGDS | |
| SCHEMBL416443 | 0.82 | METAP2 (0.53) | NPY5RNPC1RAB9ASMN1; SMN2HPGDS | |
| SCHEMBL384952 | 0.81 | NPC1 (0.61) | NPY5RNPC1RAB9ASMN1; SMN2HPGDS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10167303-B2 | Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex | UDC IRELAND LIMITED (IE) | 2019-01-01 | — | — | US | disclosed |
| EP-2802594-B1 | METAL COMPLEXES WITH DIBENZO[F,H]QUINOXALINES | UDC IRELAND LTD (IE) | 2017-04-19 | — | — | EP | disclosed |
| US-20170044194-A1 | Metal Complexes with Dibenzo[f,h]quinoxalines | UDC IRELAND LTD (IE) | 2017-02-16 | — | — | US | disclosed |
| US-20170044194-A1 | Metal Complexes with Dibenzo[f,h]quinoxalines | UDC IRELAND LTD (IE) | 2017-02-16 | — | — | US | disclosed |
| US-9472762-B2 | Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex | UDC IRELAND LIMITED (IE) | 2016-10-18 | — | — | US | disclosed |
| US-9472762-B2 | Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex | UDC IRELAND LIMITED (IE) | 2016-10-18 | — | — | US | disclosed |
| US-9362510-B2 | Electroluminescent metal complexes with benzotriazoles | BASF SE (DE) | 2016-06-07 | — | — | US | disclosed |
| US-9362510-B2 | Electroluminescent metal complexes with benzotriazoles | BASF SE (DE) | 2016-06-07 | — | — | US | disclosed |
| US-9012899-B2 | Electroluminescent metal complexes with nucleophilic carbene ligands | BASF SE (DE) | 2015-04-21 | — | — | US | disclosed |
| US-9012899-B2 | Electroluminescent metal complexes with nucleophilic carbene ligands | BASF SE (DE) | 2015-04-21 | — | — | US | disclosed |
| US-20110089407-A1 | ELECTROLUMINISCENT METAL COMPLEXES WITH DIBENZO[F,H] QUINOXALINES | BASF SE (DE) | 2011-04-21 | — | — | US | disclosed |
| EP-2112994-B1 | ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES | BASF SE (DE) | 2011-01-26 | — | — | EP | disclosed |
| US-20100108994-A1 | ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES | UDC IRELAND LIMITED (IE) | 2010-05-06 | — | — | US | disclosed |
| US-20100108994-A1 | ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES | UDC IRELAND LIMITED (IE) | 2010-05-06 | — | — | US | disclosed |
| WO-2010037667-A1 | COMPLEX SALTS | BASF SE (DE) | 2010-04-08 | — | — | WO | disclosed |
| WO-2010031738-A1 | ELECTROLUMINESCENT METAL COMPLEXES WITH AZAPYRENES | BASF SE (DE) | 2010-03-25 | — | — | WO | disclosed |
| WO-2009100991-A1 | ELECTROLUMINESCENT METAL COMPLEXES WITH DIBENZO[F,H]QUINOXALINES | BASF SE (DE) | 2009-08-20 | — | — | WO | disclosed |
| EP-2080796-A1 | Electroluminescent metal complexes with nucleophilic carbene ligands | Ciba Holding Inc. (CH) | 2009-07-22 | — | — | EP | disclosed |
| WO-2008101842-A1 | ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES | BASF SE (CH) | 2008-08-28 | — | — | WO | disclosed |
| US-7390595-B2 | Method of preparing a crosslinked polymer in an electrolyte composition | FUJIFILM CORPORATION (JP) | 2008-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10167303-B2 | Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex | NDUFS5, DDT, NDUFV2 | NPY5R 3257/4885NPC1 4669/4885RAB9A 1151/4885 |
| US-20100108994-A1 | ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES | OCIAD1, OCIAD2, OXA1L | NPY5R 3047/4885NPC1 4461/4885RAB9A 4679/4885 |
| US-20170044194-A1 | Metal Complexes with Dibenzo[f,h]quinoxalines | NDUFS2, OCIAD2, NDUFS3 | NPY5R 3897/4885NPC1 3696/4885RAB9A 717/4885 |
| US-20110089407-A1 | ELECTROLUMINISCENT METAL COMPLEXES WITH DIBENZO[F,H] QUINOXALINES | NDUFS2, NDUFS5, NDUFS3 | NPY5R 3497/4885NPC1 4653/4885RAB9A 879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.